Corresponding to upregulated TRF2 expression at 80μM,
stem cell markers like CD44 and Oct4 were also observed to be upregulated in Clonospheric HCT116 as compared to Parental HCT116 (Fig. 3a and 3b) Decreasing CD24 expression in clonospheric HCT116 was observed which correlated well with increased stem cell expression (Fig. 3b).
Not exact matches
This biomechanical
marker could be used as a rapid and cost - effective approach to enrich for
stem -
like cells in corneal transplant tissue.
For example, labeling of these
cells with
stem -
like cell associated
markers (p63, nestin, and telomerase) have heavily implicated these
cells as
stem cells [13].
Methods: Human corneas with attached scleral rims were obtained from eye banks and were assayed for telomerase activity and BrdU (bromodeoxyridine) incorporation to determine, respectively, the presence of a
stem -
like cell marker and replicative activity.
Oct - 4 is a transcription factor which has been reported to be involved in various cancers and is also
marker for cancer
stem cell like population [34, 35].
Solid tumours are reported to possess a sub set of
cells called Side Population expressing various
stem like cell markers, self - renewal capacity and ability to give rise to differentiated
cells [23, 24].
Since very few studies have demonstrated the formation of macro-metastasis from low numbers of sorted CSCs and currently proposed CSC
markers might not be sufficient to identify all
stem cell populations [13], we believe that our study presents a promising approach to isolate
stem -
like and metastatic breast CSCs as opposed to the
cell - sorting strategy based on putative
stem cell surface
markers.
Neural crest -
like stem cells (NCLSC) share many properties with aggressive melanoma
cells, such as high migratory capabilities and expression of neural crest
markers.
She plans to test whether or not molecules designed to target the
marker can block the signaling necessary for maintaining the
cells»
stem -
like properties, which could lead to new antibody - based immunotherapies for breast cancer.